Care
Gee Mathen, director of pharmacy clinical applications and technical services at Texas Children's Hospital, discusses his upcoming HIMSS24 session "Combating Counterfeit Drugs and the Drug Supply Chain Security Act."
HIMSS24
Prashant Natarajan, VP of strategy and products at H20.ai, says he is looking forward to discussing generative AI and the patient experience as well as strategies and success stories with fellow HIMSS24 attendees.
The healthcare system will translate its advanced algorithms pertaining to rapid response clinical scenarios into AvoMD's application.
The Washington D.C.-based company offers a platform to help cardiology teams transition to value-based care.
Sumit Nagpal, Cherish Health CEO, discusses his new endeavor aimed at health assurance through prevention by using in-home radar technology to track individuals, and the importance of cross-sector collaboration for better patient outcomes.
An Australian charity has recently opened up its wealth of IBD data for IBD R&D worldwide.
The cancer support provider is partnering with insurance company Allstate to provide oncology patients with behavioral change programs.
The food delivery company's engagement program will focus on providing nutritious food and tailored educational content to expectant and new mothers.
HIMSS24
Cleveland Clinic ACO's Dr. Jessica Hohman and Cleveland Clinic Florida's Dr. Richard Rothman discuss their upcoming HIMSS24 session on how the hospital system created and evolved its scalable home-based acute and post-acute care models.
The virtual care company reported a 65% increase in revenue in 2023 compared to 2022 and a 47% increase in Q4 2023 revenue compared to the previous year.